Inventor · disambiguated record
Neil M. Cowen
Also filed as: COWEN NEIL M · COWEN NEIL MADISON
19 granted patents·16 pending applications·324 citations·filing 1997–2025
96Inventor score
Top patents by PatentIndex Score
35 records- 0197US12343348B2Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2024·Granted Jul 1, 2025·2 cites·25 claims
- 0297US12178823B1Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2024·Granted Dec 31, 2024·3 cites·24 claims
- 0397US12109216B2Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2024·Granted Oct 8, 2024·3 cites·5 claims
- 0496US11786536B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2021·Granted Oct 17, 2023·4 cites·8 claims
- 0596US7572789B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2009·Granted Aug 11, 2009·74 cites·14 claims
- 0695US10058557B2Methods for treating subjects with prader-willi syndrome or smith-magenis syndromeESSENTIALIS INC·Filed 2017·Granted Aug 28, 2018·12 cites·19 claims
- 0795US9757384B2Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2015·Granted Sep 12, 2017·10 cites·14 claims
- 0894US11045478B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2019·Granted Jun 29, 2021·5 cites·17 claims
- 0994US7179902B2Use of regulatory sequences in transgenic plantsDOW AGROSCIENCES LLC·Filed 2003·Granted Feb 20, 2007·47 cites·4 claims
- 1094US5986182AInbred maize line 4SQ601Filed 1997·Granted Nov 16, 1999·16 cites·11 claims
- 1193US10456408B2Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2018·Granted Oct 29, 2019·7 cites·10 claims
- 1293US10085998B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2016·Granted Oct 2, 2018·12 cites·16 claims
- 1392US10874676B2Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndromeESSENTIALIS INC·Filed 2019·Granted Dec 29, 2020·6 cites·12 claims
- 1492US9782416B2Pharmaceutical formulations of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2014·Granted Oct 10, 2017·12 cites·10 claims
- 1591US9381202B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2013·Granted Jul 5, 2016·12 cites·21 claims
- 1691US7799777B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2006·Granted Sep 21, 2010·14 cites·36 claims
- 1788US12419895B1Methods for treating subjects with Prader-Willi syndromeESSENTIALIS INC·Filed 2025·Granted Sep 23, 2025·0 cites·26 claims
- 1887US2024252507A1Salts of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2023·Application pending·0 cites
- 1984US6331664B1Acyl-ACP thioesterase nucleic acids from maize and methods of altering palmitic acid levels in transgenic plants therewithDOW AGROSCIENCES LLC·Filed 1998·Granted Dec 18, 2001·75 cites·16 claims
- 2081US9765043B2Salts of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2014·Granted Sep 19, 2017·10 cites·6 claims
- 2177US2020237772A1Pharmaceutical formulations of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2019·Application pending·0 cites
- 2275US2021322434A1Methods for treating subjects with prader-willi syndrome or smith-magenis syndromeESSENTIALIS INC·Filed 2020·Application pending·0 cites
- 2369US2010028429A1Salts of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2009·Application pending·0 cites
- 2468US2009149451A1Pharmaceutical formulations of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2009·Application pending·0 cites
- 2568US2009148525A1Pharmaceutical formulations of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2009·Application pending·0 cites
- 2668US2019117665A1Salts of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2018·Application pending·0 cites
- 2764US2013309301A1Salts of potassium atp channel openers and uses thereofESSENTIALS INC·Filed 2012·Application pending·0 cites
- 2864US2018280405A1Pharmaceutical formulations of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2018·Application pending·0 cites
- 2964US2022233501A1Therapeutic combinationsSUPERSALUS INC·Filed 2022·Application pending·0 cites
- 3057US2010256360A1Salts of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2010·Application pending·0 cites
- 3155US2006051418A1Pharmaceutical formulations of potassium ATP channel openers and uses thereofESSENTIALIS INC·Filed 2005·Application pending·0 cites
- 3255US2020253926A1Therapeutic combinationsSUPERSALUS INC·Filed 2020·Application pending·0 cites
- 3346US2009062264A1Salts of potassium atp channel openers and uses thereofCOWEN NEIL M·Filed 2008·Application pending·0 cites
- 3440US2013040942A1Salts of potassium atp channel openers and uses thereofESSENTIALIS INC·Filed 2012·Application pending·0 cites
- 3540US2012238554A1Salts of potassium atp channel openers and uses thereofCOWEN NEIL M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neil M. Cowen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →